Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study.
about
Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencingSurvival analysis of cancer risk reduction strategies for BRCA1/2 mutation carriersProphylactic oophorectomy in premenopausal women and long-term healthIncreased cardiovascular mortality after early bilateral oophorectomyOvarian Cancer and BRCA1/2 Testing: Opportunities to Improve Clinical Care and Disease PreventionSociety of Gynecologic Oncology recommendations for the prevention of ovarian cancerFeasibility evaluation of an online tool to guide decisions for BRCA1/2 mutation carriers.Major clinical research advances in gynecologic cancer in 2015Inherited Mutations in Women With Ovarian CarcinomaA prospective study of risk-reducing salpingo-oophorectomy and longitudinal CA-125 screening among women at increased genetic risk of ovarian cancer: design and baseline characteristics: a Gynecologic Oncology Group studyThe preclinical natural history of serous ovarian cancer: defining the target for early detectionMajor clinical research advances in gynecologic cancer in 2016: 10-year special edition.A Cost-Effectiveness Evaluation of Germline BRCA1 and BRCA2 Testing in UK Women with Ovarian CancerTransferring embryos with indeterminate PGD results: the ethical implications.Acceptability of prophylactic salpingectomy with delayed oophorectomy as risk-reducing surgery among BRCA mutation carriers.Risk-reducing strategies for women carrying BRCA1/2 mutations with a focus on prophylactic surgery.Precursor lesions of high-grade serous ovarian carcinoma: morphological and molecular characteristics.Current condition of genetic medicine for hereditary breast cancer.Seeking balance: decision support needs of women without cancer and a deleterious BRCA1 or BRCA2 mutationGynaecologic challenging issues in the management of BRCA mutation carriers: oral contraceptives, prophylactic salpingo-oophorectomy and hormone replacement therapy.Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.Clinical management of hereditary breast cancer syndromes.Occult ovarian cancers identified at risk-reducing salpingo-oophorectomy in a prospective cohort of BRCA1/2 mutation carriers.The safety parameters of the study on intraductal cytotoxic agent delivery to the breast before mastectomyUse of risk-reducing surgeries in a prospective cohort of 1,499 BRCA1 and BRCA2 mutation carriersClinical management of BRCA1 and BRCA2 mutation carriers.Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study.Breast cancer in young womenHereditary breast and ovarian cancer: new genes, new treatments, new concepts.Fertility preservation and breast cancer: a reviewAdequacy of risk-reducing gynaecologic surgery in BRCA1 or BRCA2 mutation carriers and other women at high risk of pelvic serous cancer.Premalignant alterations in breast and endometrium associated with a PTEN mutation in a woman with Cowden syndrome: implications for preventive care.Online tool to guide decisions for BRCA1/2 mutation carriers.Breast and ovarian cancer risk and risk reduction in Jewish BRCA1/2 mutation carriersProspective study of breast MRI in BRCA1 and BRCA2 mutation carriers: effect of mutation status on cancer incidence.Hidden dangers: a cryptic exon disrupts BRCA2 mRNA.Efficient identification and referral of low-income women at high risk for hereditary breast cancer: a practice-based approach.The Angelina Jolie Effect in Jewish Law: Prophylactic Mastectomy and Oophorectomy in BRCA CarriersRisk-reducing Surgery in Women at Risk for Familial Breast or Ovarian Cancer.Risk-Reducing Strategies for Ovarian Cancer in BRCA Mutation Carriers: A Balancing Act.
P2860
Q24632270-F47140ED-8610-4004-AC75-23E0EC8E9614Q24654487-9E882EC0-6169-4F34-9EB7-2CC39424C349Q24655584-34DB3A23-D5AB-4506-9634-2529EB637CA5Q24658403-1C41BBAB-5F5E-4428-A191-473979A21F39Q26744525-906D32D7-26DF-40B3-8638-8343DDE77CA3Q27009306-73FF2623-955C-4B2B-8C1E-3DA354E41792Q27316521-FB3E2E1B-4786-4E4A-8C93-D9FB55189DCAQ28077183-20F9A2FD-BA1D-4B7C-8CC8-B01B79B9ED2FQ30353433-E3B2451F-A266-4BF9-B8C7-2C8C892310C0Q30431721-9A28A759-B223-42C1-8D97-9CDAA5F17DD0Q33487678-F58204EE-70B5-4A54-80F7-80BE64BDD99EQ33563963-DE9FF9A2-8FEE-4985-9A7A-FCB1721F24B7Q33606561-ADCC11D5-E78C-4289-B639-B8FA41F2B47DQ33655307-FD88054A-6540-46A4-A3AA-64510AD82B42Q33668934-A4E61E3B-6823-45CF-B2EB-79CB372C48CFQ33723561-6FA974F8-2E43-4592-B971-A557F4C8F706Q33815261-96634746-C79C-434D-B68F-BBDF45C0CCD5Q33858408-403B033A-0C99-4775-BAC9-0E7D494A77C0Q34069150-34CB989C-44E7-4501-B598-3C730860A56BQ34126089-32215551-7381-460B-A4BC-E82ED79B2E9FQ34135443-6F57B14C-F093-4A05-B69E-5D082C05C5A3Q34167563-2473E1B5-0A24-4FA4-ACA7-85D5E3C2DFA3Q34172655-9B00D217-508B-4EC7-AFF6-ACFAF1C9F3DFQ34452808-2EF14B9E-10E5-45FD-8B6F-38E42D38E760Q34475484-89B4F0E4-EA58-4AC5-A320-0A8F60D1D114Q34568554-23F314AC-9569-47B3-B006-A1A1B8190969Q34749278-936EF54A-0549-46EC-A832-3BBAA77D7E41Q34989073-D2CCDFB8-ADFC-4C25-8890-50ABF4B74587Q35019634-28058FF3-527A-42CD-817D-7C780C972C8BQ35106163-BBABA044-19AF-4F1C-ADD1-249BBAD33F73Q35219159-E503687F-D683-447B-8327-0975CEC064DBQ35642017-7FAEBB51-B5E3-4B38-8C4F-CBD5732179BFQ35808372-F7CCAF4D-D09B-4B60-A483-8BF872D98C65Q35925255-3EBD17F0-85DD-40ED-A70B-DD48E5387D20Q35930061-324A5FF9-54BC-4B1B-A7ED-FD199B830FE7Q35953549-06EDFD1E-33F3-4E72-817B-BDB0EC7F8808Q35994562-59C3B964-E848-4FC6-B28C-72563E7DA499Q36218446-27A80F46-E821-4FCE-ABB2-AD9F0FFF6786Q36295137-358DA78A-2FD4-44C6-9D81-44BC8CCE6262Q36313479-BA6B0A1D-3867-45D9-AA41-596F43650A0C
P2860
Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Mortality after bilateral salp ...... s: a prospective cohort study.
@ast
Mortality after bilateral salp ...... s: a prospective cohort study.
@en
Mortality after bilateral salp ...... s: a prospective cohort study.
@nl
type
label
Mortality after bilateral salp ...... s: a prospective cohort study.
@ast
Mortality after bilateral salp ...... s: a prospective cohort study.
@en
Mortality after bilateral salp ...... s: a prospective cohort study.
@nl
prefLabel
Mortality after bilateral salp ...... s: a prospective cohort study.
@ast
Mortality after bilateral salp ...... s: a prospective cohort study.
@en
Mortality after bilateral salp ...... s: a prospective cohort study.
@nl
P2093
P50
P1433
P1476
Mortality after bilateral salp ...... s: a prospective cohort study.
@en
P2093
Barbara L Weber
Ellen Matloff
Gail E Tomlinson
Henry T Lynch
Judy E Garber
Laura Van't Veer
Mary B Daly
Tara M Friebel
Theresa Wagner
Timothy R Rebbeck
P304
P356
10.1016/S1470-2045(06)70585-X
P577
2006-03-01T00:00:00Z